Chris Rivera
Nativis, Inc. announced today that Chris Rivera, president of the Washington Biotechnology and Biomedical Association (WBBA), founder and former CEO of Hyperion Therapeutics, was appointed to the company’s board of directors.
Nativis, Inc. announced today that Chris Rivera, president of the Washington Biotechnology and Biomedical Association (WBBA), founder and former CEO of Hyperion Therapeutics, was appointed to the company’s board of directors.